| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.000962132 |
Resistant |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.020487002 |
Resistant |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041249774 |
Sensitive |
